Nosis Bio - About the company
Nosis Bio is a funded company based in Berkeley (United States), founded in 2021 by Jim Martineau, Seth Myers and Chad Miller. It operates as a Biotech company focused on developing cell targeted delivery of therapeutic cargos for drug treatments. The company has 1197 active competitors, including 101 funded and 152 that have exited. Its top competitors include companies like WuXi AppTec, ANI Pharmaceuticals and Ipsen.
Company Details
Biotech company focused on developing cell targeted delivery of therapeutic cargos for drug treatments. To create Targeted Delivery Vehicles, it employs deep learning, generative AI, and multiplexed biochemistry. It uses technology to address the need in drug delivery and enable the treatments for patients.
Key Metrics
Founded Year
2021
Location
Berkeley, United States
Stage
Funding Raised
Investors
Ranked
143rd among 1197 active competitors
Similar Companies
Sign up to download Nosis Bio's company profile
Nosis Bio's funding and investors
Nosis Bio is a funded company. Nosis Bio has 1 institutional investor.
View details of Nosis Bio's funding rounds and investors
Nosis Bio's founders and board of directors
Founder? Claim ProfileThe founders of Nosis Bio are Jim Martineau, Seth Myers and Chad Miller. Jim Martineau is the CEO of Nosis Bio.
Here are the details of Nosis Bio's key team members:
- Jim Martineau: Co-Founder & CEO of Nosis Bio.
- Seth Myers: Co-Founder of Nosis Bio.
- Chad Miller: Co-Founder of Nosis Bio.
View details of Nosis Bio's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Nosis Bio's Competitors and alternates
Top competitors of Nosis Bio include WuXi AppTec, ANI Pharmaceuticals and Ipsen. Here is the list of Top 10 competitors of Nosis Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | WuXi AppTec 2000, Shanghai (China), Public | Provider of CRO and CDMO services | $40M | 79/100 | |
2nd | ANI Pharmaceuticals 1996, Baudette (United States), Public | Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets | - | 64/100 | |
3rd | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 63/100 | ||
4th |  Avadel Pharmaceuticals 1990, Dublin (Ireland), Acquired | Pharma company with proprietary drug delivery tools and drug for narcolepsy | - | 61/100 | |
5th |  Zuellig Pharma 1992, Singapore (Singapore), Funding Raised | Provider of clinical research, quality management, logistics, and clinical trial supply services | - | 61/100 | |
6th | Eurofins Scientific 1987, Luxembourg (Luxembourg), Public | Provider of laboratory testing services and CRO contract research services | - | 61/100 | |
7th |  Precision Medicine Group 2012, Bethesda (United States), Late Stage | Provider of clinical research, development, and commercialization services for life sciences | $532M | 60/100 | |
8th | Arecor 2007, Cambridge (United Kingdom), Public | Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery | $8M | 58/100 | |
9th | PharmaJet 2005, Golden (United States), Series B | Provider of needle-free injection technology | $59.4M | 58/100 | |
10th |  EVERSANA 2014, Milwaukee (United States), Funding Raised | Provider of consulting services for drug pricing access, reimbursement, and regulatory support | - | 57/100 | |
143rd |  Nosis Bio 2021, Berkeley (United States), Funding Raised | Biotech company focused on developing cell targeted delivery of therapeutic cargos for drug treatments | - | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Nosis Bio's competitors? Click here to see the top ones
Nosis Bio's Investments and acquisitions
Nosis Bio has made no investments or acquisitions yet.
Reports related to Nosis Bio
Here is the latest report on Nosis Bio's sector:
News related to Nosis Bio
•
Nosis Bio Announces Development Candidate Nomination for Lead Fibrosis ProgramBusiness Wire•Jul 31, 2025•Nosis Bio
•
Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicinesBioSpectrum Asia•Mar 13, 2025•Daiichi Sankyo, Nosis Bio
•
•
Daiichi Sankyo, Johnson & Johnson Partner With Rna Delivery Startup Nosis BioEndPoints News•Mar 10, 2025•Nosis Bio, Daiichi Sankyo, Johnson & Johnson
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Nosis Bio
Explore our recently published companies
- Antheia Resorts - Pune based, Unfunded company
- ranchmansfarmandfeed.com - 2021 founded, Unfunded company
- Xperience ALT - San Francisco based, Unfunded company
- PACKAGING4RETAIL - Fort Lauderdale based, 2011 founded, Unfunded company
- IAG Consulting - Hermitage based, 2021 founded, Unfunded company
- Namibian Broadcasting Corporation (NBC) - Namibia based, 1991 founded, Unfunded company
